Insulin-like factor 3: A new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 6, 2007, Pages 2066-2073

  Gambineri, Alessandra ^a   Patton, Laura ^a   De Iasio, Rosaria ^a   Palladoro, Federica ^a   Pagotto, Uberto ^a   Pasquali, Renato ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BUSERELIN; GONADOTROPIN; INSULIN LIKE FACTOR 3; LUTEINIZING HORMONE; PEPTIDE HORMONE; PROGESTERONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; HYPERANDROGENISM; OBESITY; OUTCOME ASSESSMENT; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE;

RATTUS;

EID: 34347233125     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1678     Document Type: Article

References (39)

1. Ivell R, Hartung S, Anand-Ivell R 2005 Insulin-like factor 3: where are we now? Ann NY Acad Sci 1041:486-496
2. Zimmermann S, Schöttler P, Engel W, Adham IM 1997 Mouse Leydig insulinlike (Ley I-L) gene: structure and expression during testis and ovary development. Mol Reprod Dev 47:30-38
3. Nef S, Parada LF 1999 Cryptorchidism in mice mutant for Insl3. Nat Genet 2:295-299
4. Zimmermann S, Steding G, Emmen JM, Brikmann AO, Nayernia K, Holstein AF, Engel W, Adham IM 1999 Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13:681-691
5. Nichols N, Binta H, Fields PA, Drost M, Chang S-M, Ivell R, Fields MJ 2005 Immunohistochemical localization of relaxin-like factor/insulin-like peptide-3 in the bovine corpus luteum. Ann NY Acad Sci 1041:506-509
6. Roche PJ, Butkus A, Wintour EM, Tregear G 1996 Structure and expression of Leydig insulin-like peptide mRNA in the sheep. Mol Cell Endocrinol 121:171-177
7. Nef S, Parada LF 1999 Cryptorchidism in mice mutant for Insl3. Nat Genet 2:295-299
8. Spanel-Borowski K, Schäfer I, Zimmermann S, Engel W, Adham IM 2001 Increase in final stages of follicular atresia and premature decay of corpora lutea in Insl3-deficient mice. Mol Reprod Dev 58:281-286
9. Irving-Rodgers HF, Bathgate RA, Ivell R, Domagalski R, Rodgers RJ 2002 Dynamic changes in the expression of relaxin-like factor (Insl3), cholesterol side-chain cleavage cytochrome P450, and 3β-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol Reprod 66:934-943
10. Kawamura K, Kumagai J, Sudo S, Chun SY, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RAD, Hsueh AJW 2004 Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA 101:7323-7328
11. Foresta C, Bettella A, Vinanzi C, Dabrilli P, Meriggiola MC, Garolla A, Ferlin A 2004 Insulin-like factor 3: a novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab 89:5952-5958
12. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
13. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D 2003 Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 18:598-603
14. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248-2256
15. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SSC 1996 Insulin, somatotropic, and luteinizing hormone axes in non-obese and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 81:2854-2864
16. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE 2003 Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682-4688
17. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R 1998 Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876-1880
18. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
19. Gambineri A, Pelusi C, Genghini S, Morselli-Labate AM, Cacciari M, Pagotto U, Pasquali R 2004 Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 60:241-249
20. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 377-384
21. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognini GE, Filicori M, Morselli-Labate AM 2000 Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85:2767-2774
22. World Health Organization 2000 Obesity: Preventing and Managing the Global Epidemic, Report of a World Health Organization consultation on obesity. Tech Rep Ser 894. Geneva: World Health Organization
23. Swanson M, Sauerbrei EE, Cooperberg PL 1981 Medical implications of ultrasonically detected polycystic ovaries. J Clin Ultrasound 9:219-222
24. Balen AH, Laven JS, Tan SL, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505-514
25. Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM 1999 The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment. Clin Endocrinol (Oxf) 50:517-527
26. Vicennati V, Pasquali R 2000 Abnormalities of the hypothalamic-pituitaryadrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and peripheral alteration. J Clin Endocrinol Metab 85:4093-4098
27. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
28. 1987 Immunoassay: a practical guide. Chan DW, Perlstein MT, eds. New York: Academic Press; 71
29. Norusis MJ 1990 SPSS/PC + 4.0 base and advanced statistics manuals. Chicago: SPSS
30. Dixon WJ, Brown MB, Engelman L, Jennrich RI 1990 BMDP statistical software manual. Berkeley, CA: University of California Press
31. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R 2002 Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883-896
32. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC 1999 The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20:535-582
33. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
34. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G 1977 Gonadotropin releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269:338-340
35. Balvers M, Spiess AN, Domagalski R, Hunt N, Kilic E, Mukhopadhyay AK, Hanks E, Charlton HM, Ivell R 1998 Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 139:2960-2970
36. Hombach-Klonisch S, Schön J, Kehlen A, Blottner S, Klonisch T 2004 Seasonal expression of INSL3 and Lgr8/INSL3 receptor transcripts indicates variable differentiation of Leydig cells in the roe deer testis. Biol Reprod 71:1079-1087
37. Bay K, Hartung S, Ivell R, Schumacher M, Jürgensen D, Jorgensen N, Holm M, Skakkebaek NE, Andersson A-M 2005 Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab 90:3410-3418
38. Bay K, Matthiesson KL, McLachlan RI, Andersson A-M 2006 The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. J Clin Endocrinol Metab 91:1108-1111
39. Ferlin A, Garolla A, Rigon F, Caldogno LR, Lenzi A, Foresta C 2006 Changes in serum Insulin-like factor 3 (INSL3) during normal male puberty. J Clin Endocrinol Metab 91:3426-3431